Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

AI-300 effective in preliminary clinical study

May 10, 1996

No Comments

Verteporfin effective in treating severe age-related macular degeneration in early trials

May 3, 1996

No Comments

Toray's MIP for treatment of ophthalmological disorders

May 3, 1996

No Comments

EPC-K claimed for ophthalmic use

May 3, 1996

No Comments

ISV-205 research results presented at vision conference

April 26, 1996

No Comments

New alpha2-adrenoceptor agonist reported by Allergan

April 12, 1996

No Comments

FDA approves Laser system for myopia

April 5, 1996

No Comments

Pharmos completes loteprednol etabonate trial

March 15, 1996

No Comments

AI-300 for uveitis

March 15, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

AI-300 effective in preliminary clinical study

Verteporfin effective in treating severe age-related macular degeneration in early trials

Toray's MIP for treatment of ophthalmological disorders

EPC-K claimed for ophthalmic use

ISV-205 research results presented at vision conference

New alpha2-adrenoceptor agonist reported by Allergan

FDA approves Laser system for myopia

Pharmos completes loteprednol etabonate trial

AI-300 for uveitis

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Ocular RSS

Ocular
RSS